NFKB1 variants were associated with the risk of Parkinson´s disease in male-Reference-Cited by-同舟云学术

NFKB1 variants were associated with the risk of Parkinson´s disease in male

Published:2024-02-28 Issue:7 Volume:131 Page:773-779
ISSN:0300-9564
Container-title:Journal of Neural Transmission
language:en
Short-container-title:J Neural Transm

Author:

Perez-Oliveira Sergio,Vazquez-Coto Daniel,Pardo Sara,Blázquez-Estrada Marta,Menéndez-González Manuel,Siso Pablo,Suárez Esther,García-Fernández Ciara,Fages Beatriz de la Casa,Coto Eliecer,Álvarez Victoria

Funder

Instituto de Salud Carlos III

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00702-024-02759-1.pdf

Reference40 articles.

1. Anantha J, Goulding SR, Tuboly E, O’Mahony AG, Moloney GM, Lomansey G, McCarthy CM, Collins LM, Sullivan AM, O’Keeffe GW (2022) NME1 protects against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell models of Parkinson’s Disease. Mol Neurobiol 59(1). https://doi.org/10.1007/s12035-021-02569-6

2. Baiguera C, Alghisi M, Pinna A, Bellucci A, De Luca MA, Frau L, Morelli M, Ingrassia R, Benarese M, Porrini V, Pellitteri M, Bertini G, Fabene PF, Sigala S, Spillantini MG, Liou HC, Spano PF, Pizzi M (2012) Late-onset parkinsonism in NFκB/c-Rel-deficient mice. Brain 135(9). https://doi.org/10.1093/brain/aws193

3. Baltus THL, Morelli NR, de Farias CC, Trugilo KP, Okuyama NCM, de Oliveira KB, de Melo LB, Smaili SM, Barbosa DS (2021) Association of -94 ATTG insertion/deletion NFkB1 and c.*126G > A NFkBIA genetic polymorphisms with oxidative and nitrosative stress biomarkers in Brazilian subjects with Parkinson’s Disease. Neuroscience Letters, 740. https://doi.org/10.1016/j.neulet.2020.135487

4. Bellucci A, Bubacco L, Longhena F, Parrella E, Faustini G, Porrini V, Bono F, Missale C, Pizzi M (2020) Nuclear Factor-κB dysregulation and α-Synuclein Pathology: critical interplay in the pathogenesis of Parkinson’s Disease. Front Aging Neurosci 12. https://doi.org/10.3389/fnagi.2020.00068

5. Camblor DG, Miranda D, Albaiceta GM, Amado-Rodríguez L, Cuesta-Llavona E, Vázquez-Coto D, Gómez de Oña J, García-Lago C, Gómez J, Coto E (2022) Genetic variants in the NF-κBsignaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients. Hum Immunol 83:8–9. https://doi.org/10.1016/j.humimm.2022.06.002